Thanks for joining DividendStocks.com, the daily newsletter built for dividend and income investors like you. We’re thrilled to have you on board and can’t wait to help you discover the best dividend opportunities out there. Before we can start sending your daily insights, please take a quick moment to confirm your subscription: Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Why wait? Let’s get your dividend journey started! Click Here to Start Discovering Top Income-Generating Stocks See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Just For You Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025Reported by Leo Miller. Article Published: 1/3/2026. 
Article Highlights - While small caps as a whole generated lower returns than large caps in 2025, three interesting names bucked this narrative.
- A cancer screening company and two satellite operators saw their shares rise 300% or more.
- See where analysts are forecasting upside and understand vital considerations pertaining to smaller stocks.
In 2025, small-cap stocks generally lagged. The Russell 2000 Index, which tracks 2,000 U.S. small-cap stocks, returned about 13% for the year — well below the S&P 500's roughly 18% total return. Despite the group's underperformance, three names delivered exceptional gains in 2025 — each up 300% or more. They began 2025 in small-cap territory but, after their rallies, have moved into mid-cap valuations. Below we highlight those three stocks and the drivers behind their big years. GRAL Catapults on Early Cancer Detection Enthusiasm Ray Dalio Says "Gold Is the Future". This ETF Pays You 64% to Own It
Ray Dalio is urging investors to shift 10% of their portfolio into gold. But one ETF lets you go a step further: earn up to $1,152/month.
It's part of a new wave of funds that pay you every 30 days. Watch the video now and discover the #1 fund for monthly payouts. Healthcare stock GRAIL (NASDAQ: GRAL) climbed roughly 380% in 2025. Its market capitalization grew from well under $1 billion to about $3.3 billion. GRAIL's core product is the Galleri multi-cancer early detection test. Early detection improves survival, which has driven strong interest in Galleri. Only about five cancers have standardized screening methods, yet roughly 70% of cancer deaths stem from other types. Galleri was designed to detect more than 50 different cancers. In a recent study, GRAIL reported that adding Galleri to traditional screening increased early cancer detection by more than sevenfold. Currently, Galleri sales are largely out-of-pocket. GRAIL expects to apply for Premarket Approval (PMA) from the U.S. Food and Drug Administration in the first quarter of 2026; approval would make commercial insurance coverage far more likely and could open a large new sales channel, which has excited investors. The MarketBeat consensus price target of $97.50 reflects analyst optimism and implies roughly 14% upside. PL Blasts Off, Combining AI with Geospatial Imagery Planet Labs PBC (NYSE: PL) posted a blockbuster 2025, with shares up nearly 390%. The company operates hundreds of satellites that collect medium- to high-resolution Earth imagery and pairs that data with artificial intelligence to help customers make decisions. Revenue comes from subscriptions to its cloud-based platform and satellite services. Demand has been especially strong among government customers. Its Dec. 10 earnings report sent shares up 35% in a day, citing defense and intelligence revenue growth of more than 70%. Planet reported a backlog of about $735 million — roughly 2.6 times its trailing 12‑month revenue of $282 million — creating a runway for growth. The company also recorded positive free cash flow for the second consecutive quarter. The MarketBeat consensus price target of $14.74 implies roughly 25% downside from current levels. However, the average of targets updated after the company's latest earnings is $18.19, which would imply about 7.7% downside. Planet Labs remains worth watching — a meaningful pullback could present a more attractive entry point. Updated Targets Eye Strong Upside in VSAT After Huge 2025 Run Finally, Viasat (NASDAQ: VSAT) gained approximately 305% in 2025, bringing its market cap to about $4.7 billion. Viasat is another satellite operator, but it focuses on internet and data connectivity rather than consumer-focused telecom. Its customer mix emphasizes aviation, maritime and government markets, making it somewhat different from peers like AST SpaceMobile (NASDAQ: ASTS). Viasat provides in-flight connectivity to thousands of commercial and business aircraft. The U.S. government was the company's largest customer in fiscal 2025, accounting for 18% of revenue (Viasat is currently in fiscal 2026). Revenues grew just 2% in the most recent quarter, but contract awards increased 17% to nearly $1.5 billion and backlog rose to almost $3.9 billion. The MarketBeat consensus price target of $32.75 implies about 5% downside. However, price targets revised after the company's Nov. 7 earnings report average $49, suggesting roughly 37% upside potential. GRAL, PL, VSAT: Deep Research Is Paramount GRAL, PL and VSAT delivered remarkable returns in 2025, but investors should remember that smaller stocks — particularly those that have run hard — can be highly volatile. Confidence in a company's long-term fundamentals and thorough due diligence are essential before adding such names to a portfolio.
| 
